summary
Introduced
01/16/2025
01/16/2025
In Committee
01/30/2025
01/30/2025
Crossed Over
Passed
Dead
Introduced Session
2025 Regular Session
Bill Summary
Establishes a payment rate not to exceed cost plus forty per cent for nonprescription drugs, over-the-counter drugs, or nonlegend drugs for workers' compensation purposes, subject to certain conditions. Effective 7/1/3000. (HD1)
AI Summary
This bill establishes clear guidelines for reimbursement of nonprescription, over-the-counter, and nonlegend drugs in workers' compensation cases. Specifically, the bill limits payments for these drugs to no more than the cost of the drug plus 40%, addressing concerns about inflated drug pricing that can increase workers' compensation insurance costs. To be reimbursable, the drug must be clinically established as necessary for treating a work-related injury, and must be dispensed by a physician. The bill defines these terms by referencing existing state law definitions, and allows providers to seek reimbursement for general excise taxes associated with the drug. The legislation aims to provide transparency and control in drug reimbursement for workers' compensation claims, preventing potential overcharging while ensuring that necessary medications are still accessible to injured workers. The bill will take effect on July 1, 3000, and does not impact any rights, penalties, or proceedings that occurred before its effective date.
Committee Categories
Business and Industry, Labor and Employment
Sponsors (7)
Cory Chun (D)*,
Lisa Kitagawa (D)*,
Michael Lee (D)*,
Lisa Marten (D)*,
Scot Matayoshi (D)*,
Jackson Sayama (D)*,
Jenna Takenouchi (D)*,
Last Action
Carried over to 2026 Regular Session. (on 12/08/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...